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ABSTRACT OF THE DISSERTATION 
 
The role of host inflammation and the commensal microbiota in the pathogenesis of medication-
related osteonecrosis of the jaw 
 
by 
 
Drake Winslow Williams 
Doctor of Philosophy in Oral Biology 
University of California, Los Angeles, 2019 
Professor Reuben H. Kim, Chair 
 
 
 Bisphosphonates (BPs) and denosumab (Dmab) are anti-resorptive drugs that are clinically 
used to treat bone disorders like osteoporosis and bone metastases. A detrimental side effect of 
these drugs that uniquely occurs in the oral cavity is BP- and Dmab-related osteonecrosis of the 
jaw (collectively called medication-related osteonecrosis of the jaw, or MRONJ), clinically 
defined as exposed necrotic bone with unclosed overlaying oral mucosa for at least 8 weeks. 
Although the first report of ONJ by BPs appeared in 2003, the exact pathophysiology of MRONJ 
is still largely unknown. Our laboratory has been working to examine and elucidate the 
pathophysiology of MRONJ.  Previously, we established mouse models for MRONJ utilizing 
bisphosphonate and αRANKL antibody and identified that woven bone formation and inhibition 
of bone resorption are hallmarks of murine MRONJ lesions. We also utilized semi-unbiased 
gene profiling to identify and validate the importance of IL36 signaling in MRONJ pathogenesis.  
 MRONJ often occurs following a dental intervention such as a tooth extraction which is 
typically performed to eliminate localized periodontal or periapical inflammation. Periodontal 
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disease is caused by polymicrobial infection and subsequent host immune response; thus, we 
hypothesize that local inflammation driven by host responses plays a critical role in MRONJ 
development. In this study, we found that 1) Long-term (10 weeks) ligature-induced periodontitis 
(L-LIP) exacerbates bone loss and local expression of Il17a; 2) Host response, not microbial 
community composition, drives bone loss in L-LIP; and 3) L-LIP combined with BP and 
extraction leads to significantly more necrotic bone formation than short-term (3 weeks) ligature-
induced periodontitis. Additionally, we utilized a microbiota-depletion model to identify the role of 
the commensal microbiota in inflammation-induced osteonecrosis development and found that 
1) MRONJ lesions have an increased number of infiltrating bacteria compared to vehicle 
controls; 2) The commensal microbiota partially protects against the development of 
osteonecrosis following extraction of periodontally diseased teeth, but not healthy teeth. 
Collectively, we show that the duration of periodontal disease is correlated with increased 
osteonecrosis and the oral microbiota plays a protective role in ligature-induced osteonecrosis 
development. 
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Introduction 
  
 2 
 
The oral cavity is a unique and important anatomic site in the human body that harbors dentition 
required for prandial nutrient extraction, accommodates a diverse commensal microbiota, and is 
the first site where food antigens are encountered prior to entering the GI tract. The sequela of a 
disruption in any of these facets of the oral cavity includes decreased quality of life, poor nutrient 
extraction, commensal microbiota dysbiosis and opportunistic infection, bacteremia and/or 
septicemia, and in the case of incompatible antigen encounter, anaphylaxis and death. 
Medication-related osteonecrosis of the jaw (MRONJ) is a nonhealing wound involving 
epithelium, connective tissue and bone that is unique to the oral-maxillofacial region and 
significantly alters quality of life. MRONJ is clinically defined as exposed necrotic bone and 
unclosed overlaying oral mucosa for at least 8 weeks in patients with a history of antiresorptive 
or antiangiogenic therapy who have not experienced radiation therapy in the maxillofacial region 
(Ruggiero et al., 2014). It occurs in the mandible and/or maxilla of patients taking antiresorptive 
or antiangiogenic medicaments for bone degenerative diseases such as osteoporosis or as an 
adjunctive therapy to minimize cancerous bone metastases. The multifactorial etiology of 
MRONJ has led to an incomplete understanding of disease pathogenesis since the first cases 
were reported in 2003 (Marx, 2003).  
The goal of this body of work was to understand the etiologic factors that spark MRONJ lesion 
development by utilizing clinically relevant mouse models. Since only a subset of patients and 
mice on antiresorptive therapy (ART) develop MRONJ lesions, we compared animals that did or 
did not develop MRONJ. Treatment group stratification led to the observation that impaired 
bone resorption and woven bone formation are hallmarks of MRONJ lesions. Additionally, we 
identified and described a critical role for pro-inflammatory cytokines including interleukin 36 
(IL36) in the development of MRONJ that has potential therapeutic utility. Subsequent studies 
isolated the role of chronic periodontal inflammation and the commensal microbiota in MRONJ 
lesion development. The tissue-specific nature of MRONJ requires specialized study of the 
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unique features of the oral barrier and the interplay between barrier structure and function, 
wound healing, and host-microbiota interactions.  
The Oral Barrier: Structure and Function 
The human body contains several mucosal tissues that are strategically located in areas that 
have the potential to encounter external pathogens or insults, including the skin, GI tract, and 
the oral cavity. Maintenance of tissue homeostasis requires a delicate balance between immune 
surveillance and response at barrier tissues: too great a response can severely damage the 
host, while anergic responses can lead to barrier penetration and systemic infection (Belkaid 
and Harrison, 2017). In addition to efficient recruitment and maintenance of local innate and 
adaptive immune populations, barrier tissues rely on physical characteristics to maintain their 
integrity. The oral mucosa is generally comprised of an outer layer of stratified squamous 
epithelium and an inner layer of dense connective tissue, often referred to as the lamina propria 
(Winning and Townsend, 2000). Within the oral cavity, there are specific location-dependent 
modifications to the mucosa which correspond to the primary function of the tissue. The 
masticatory mucosa of the gingiva and hard palate are modified to have a mechanically tough 
epithelial covering that consists of a basal layer with undifferentiated epithelial cells, a granular 
layer with membrane-coating granules that contribute to barrier impermeability, and a highly 
keratinized layer that resists damage from mastication. The lining mucosa of the lips, cheeks, 
vestibule, inferior tongue and floor of mouth is non-keratinized enabling distension at the cost of 
increased susceptibility to physical damage. Specialized mucosa on the dorsal tongue consists 
of a mixture of keratinized papillae and non-keratinized interpapillary regions (Winning and 
Townsend, 2000).  
One unique anatomic feature of the oral cavity is the dentogingival junction, which is the 
interface between the tooth and gingiva. The dentogingival junction is the weakest part of the 
oral barrier due to the connection between mucosa and teeth, called the junctional epithelium, 
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that lacks tight junctions and is therefore susceptible to pathogen infiltration (Bosshardt and 
Lang, 2005). Indeed, the niche located directly adjacent to the dentogingival junction is 
colonized by commensal bacteria that, if allowed to accumulate, can become pathobionts and 
cause local inflammation leading to a host-mediated destruction of alveolar bone in a process 
clinically known as periodontitis (Darveau, 2010).  
Periodontal Disease 
Periodontitis is a chronic, slowly progressing infectious and inflammatory disease that 
compromises oral barrier integrity at the site of the dentogingival junction. Historically, it was 
believed that periodontal disease was caused by a group of bacteria called the red complex 
(Porphyomonas gingivalis, Tannerella forsythia, and Treponema denticola) based on their 
association with severe periodontal disease (Socransky et al., 1998). However, advances in 
metagenome and transcriptome sequencing as well as mechanistic studies have enabled a 
better understanding of the periodontitis-associated microbiome which supports a new model of 
polymicrobial synergy and dysbiosis. In this model, disease results from an imbalance in the 
oral flora, where multiple species work in concert to develop a pathogenic environment that 
leads to destructive host responses. Microbial immune subversion by keystone pathogens is a 
central feature of this model, and may explain why host response is varied across populations 
(Hajishengallis, 2015). Clinically, periodontitis is preceded by gingivitis, which is a mild and 
reversible form of periodontal disease characterized by inflamed gingiva, pseudopocket 
formation and bleeding, with little to no discomfort and no alveolar bone loss. Left untreated, 
gingivitis can advance to periodontitis, which is characterized by supra/subgingival plaque 
accumulation, progressive attachment loss, and alveolar bone loss and may eventually 
necessitate tooth removal (Fig. 1A, Klokkevold et al., 2018).  
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Figure 1. Visual representation of osteomucosal tissue in periodontal disease.  
A. In periodontal health (left), biofilm made of symbiotic bacteria colonize the surface of the tooth adjacent to the 
gingiva. The gingiva is pink, stippled and does not bleed when probed with a dull instrument. Although there is a 
basal bone homeostasis, there is no appreciable bone resorption. In periodontal disease (right), the community 
composition of the bacterial biofilm changes if bacterial aggregation is not removed by dental hygiene practices. The 
biofilm supports the growth of pathobionts, which elicit host responses that include gingival inflammation and an 
increase in bone resorption by osteoclasts. B. Placement of a suture at the cemento-enamel junction is an artificial 
method to induce periodontitis in rodents (called ligature-induced periodontitis, LIP).   
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The study of periodontal disease has been active for over 60 years and has involved human 
subjects as well as a plethora of mammalian model organisms. As a result, several animal 
models have been developed to replicate periodontal disease pathogenesis. The ligature model 
is technically challenging but effective at inducing inflammation and periodontal bone loss by 
enabling accumulation of dental plaque and micro-ulceration at the dentogingival junction, which 
facilitates pathogen invasion into the connective tissue (Figure 1B, Graves et al., 2012). 
Chapters 2 and 3 of this work utilize the ligature model to study the role of short- and long-term 
ligature placement and understand the role of the commensal microbiota in MRONJ 
pathogenesis, respectively. Infection models utilizing known amounts of individual bacteria 
delivered in food also mimic the pathologic bone loss and inflammation associated with 
periodontal disease (Li et al., 2010). Similarly, introduction of human strains of periodontal 
pathogens by oral gavage has proven effective at inducing an immune response comparable to 
that seen in humans (Bainbridge et al., 2010). Finally, local injection of the gram-negative 
bacterial cell wall component lipopolysaccharide into gingival tissue enables the study of innate 
immune response in periodontal disease pathogenesis (Buduneli et al., 2007). Each of these 
models has inherent limitations, but they also enable the study of discrete components of 
periodontal disease pathology. 
Oral Mucosal Wound Healing 
In any barrier tissue, expedient resolution of barrier integrity following exogenous insult is 
critical. Compared to the nuanced barrier defect at the dentogingival junction in periodontal 
disease, an acute trauma such as a tooth extraction results in a notable barrier defect that is 
resolved by wound healing. This multi-step and interconnected process requires communication 
between the gingival epithelium, connective tissue and the bone. The normal response to injury 
involves 3 overlapping but distinct phases: activation of inflammation, de novo tissue formation, 
and tissue remodeling (Gurtner et al., 2008). Immediately following injury, components of the 
coagulation cascade are activated, inflammation-related genes are upregulated, and innate 
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immune cells are recruited in order to stop blood loss and prevent infections. Once a clot is 
formed by platelets and hemostasis is achieved, a fibrin matrix is formed which acts as the 
scaffold upon which tissue formation occurs (Grose and Werner, 2004). 
The second major phase of extraction socket healing begins with epithelial closure. This 
orchestrated process starts when basal epithelial cells alter their phenotype to closely resemble 
a migrating mesenchymal cell (Odland and Ross, 1968). Basal epithelial cells then proliferate 
and migrate across the wound bed, reverting back to their polarized cell phenotype to assist in 
the regeneration of the basement membrane (Larjava et al., 2011). Another essential response 
in the granulation tissue formation process is angiogenesis, as the blood is a major source of 
nutrients for new cells that are generated during granulation tissue formation (Carmeliet, 2003). 
Epithelial cell expansion described above occurs concurrently with myofibroblast and stromal 
progenitor cell proliferation in order to initiate the tissue regeneration phase (Pretheeban et al., 
2012). Site-specific soluble signals that originate from epithelial cells, fibroblasts, salivary gland 
cells, vascular endothelial cells, and nerve cells drive myofibroblast and stromal progenitor cell 
differentiation, migration, and proliferation (Smith and Martínez, 2018). Once myofibroblasts and 
stromal cells migrate to the wound bed, they proliferate and rapidly produce extracellular matrix 
components including collagen, which is mediated by transforming growth factor β1 (Schrementi 
et al., 2008; Klass et al., 2009). Previously we identified woven bone formation as a distinct 
feature absent in MRONJ-like lesions (Williams et al., 2014) and we showed that collagen 
deposition by gingival mesenchymal stem cells is critical in MRONJ pathogenesis due to its role 
as a scaffold for woven bone formation (Kim et al., 2017).  
The final phase in extraction socket healing is tissue remodeling, whereby unorganized 
extracellular matrix proteins are degraded by matrix metalloproteinases and replaced at a much 
slower rate to return the tissue to a state that closely resembles uninjured tissue (Gurtner et al., 
2008). Importantly, the cells involved in rapid tissue formation (myofibroblasts and stromal cells) 
 8 
 
undergo apoptosis to make room for fibroblasts which secrete extracellular matrix components 
at a slower pace (Desmoulière et al., 1995; Zhang et al., 2004). Finally, inflammation associated 
genes and cells including macrophages are subdued to reduce the development of scar tissue 
(Mak et al., 2009).  
Medication-Related Osteonecrosis of the Jaw: Overview 
Bisphosphonates (BP) are anti-resorptive drugs commonly prescribed to treat bone disorders 
like osteoporosis and recently they have been utilized in the treatment of bone metastases in 
cancer patients (Drake et al., 2008). A side effect of anti-resorptive drugs like BPs is that long-
term users are at higher risk of developing osteonecrosis of the jaw (ONJ), clinically defined as 
exposed necrotic bone and unclosed overlaying oral mucosa for at least 8 weeks (Ruggiero et 
al., 2014). Nitrogen containing bisphosphonates, which include the most recent, most potent, 
and currently used generation of bisphosphonates, act by disrupting the enzymatic activity of 
farnesyl pyrophosphate synthase. FPPS is a key regulatory enzyme in the mevalonate pathway 
that ultimately leads to the production of steroids, cholesterol, and post-translational protein 
prenylation. In osteoclasts, this is especially important because BPs inhibit the isoprenylation of 
proteins such as Rho, Rac and Rab. These proteins are critical in forming the ruffled border 
characteristic of active osteoclasts and without proper post-translational modification, 
osteoclasts undergo apoptosis (Drake et al., 2008). Denosumab is a monoclonal antibody 
targeting RANKL, which is a required co-factor for terminal osteoclast differentiation. Thus, 
when Denosumab binds to RANKL, RANKL can no longer bind to its receptor on osteoclast 
precursors and no new mature osteoclasts are made (Bridgeman and Pathak, 2011). Although 
the mechanism of action for BP and Denosumab are diverse, they both cause MRONJ 
suggesting that ONJ pathogenesis is likely due to inhibition of common cellular processes rather 
than a drug-specific effect. Furthermore, a completely different class of drugs targeting 
angiogenesis have also been shown to play a causal role in ONJ development, and 
consequently, the current naming scheme for this condition was changed to a more broad 
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“medication” related osteonecrosis of the jaw (MRONJ) in 2014 (Ruggiero et al., 2014). The first 
report of MRONJ in the literature comes from a case detailed by Marx, who identified 36 
patients that developed “painful exposed avascular bone” following nitrogen-bisphosphonate 
treatment (Marx, 2003). In a letter to the editor, Marx aptly identified that 78% of these patients 
developed this condition following a tooth extraction. Since then, the bone phenotype now 
known as MRONJ, has been extensively studied in numerous clinical trials involving 
bisphosphonates (Lyles et al., 2007; Grbic et al., 2008; McClung et al., 2009; Grbic et al., 2010; 
Boonen et al., 2012; Sambrook et al., 2012) and denosumab (Fizazi et al., 2011; Henry et al., 
2011; Scagliotti et al., 2012; Smith et al., 2012; Chawla et al., 2013; Henry et al., 2014). 
In addition to inhibiting osteoclast resorption and stalling the progression of bone degenerative 
diseases such as osteoporosis and Paget’s disease, anti-resorptive drugs have proven effective 
for cancer therapy which has led to an increase in dosing regimen and the total patient pool that 
are at risk for developing MRONJ. Cumulative incidence of MRONJ for patients taking 
intravenous (IV) BPs or Dmab for cancer is approximately the same, conservatively estimated at 
around 1%, and occurs in approximately 0.1% of patients taking oral bisphosphonates for 
osteoporosis and other bone degenerative diseases (Ruggiero et al., 2014). 
MRONJ Pathogenesis Hypotheses 
The pathogenesis of MRONJ thus far appears to be multifactorial, and a number of empirically 
based hypotheses have emerged to explain its etiology. There are five leading areas of 
research focus on MRONJ pathogenesis: 1) inhibition of bone remodeling, 2) inflammation and 
microbial infection, 3) altered immune response, 4) soft tissue toxicity, and 5) angiogenesis 
inhibition (Aghaloo et al., 2015; Chang et al., 2018).  
Bone Remodeling Inhibition 
Given that all medications currently known to cause MRONJ have either a direct or indirect 
effect on bone resorption, a logical MRONJ pathophysiology theory would include altered bone 
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remodeling. The incorporation of BPs into bone is directly proportional to the local rate of bone 
turnover (Cremers and Papapoulos, 2011), and increased mechanical load experienced by the 
jaws during mastication coupled with increased collagen content compared to long bones 
contribute to a higher rate of bone turnover in the jaws (Sasaki et al., 2010). Interestingly, a 
study using a fluorescently labeled BP showed that sites with increased bone turnover including 
extraction sockets and areas with periapical inflammation incorporate increased amounts of BP 
(Cheong et al., 2014). Additionally, we have previously reported that impaired bone resorption is 
associated with MRONJ lesions in mice (Williams et al., 2014). Taken together, there is strong 
evidence that supports that bone remodeling inhibition is central in MRONJ development. 
Inflammation and Microbial Infection 
The fact that only a small percentage of patients taking antiresorptive or antiangiogenic therapy 
develop MRONJ suggests that there is an intrinsic factor that, when combined with 
antiresorptive therapy, leads to MRONJ development. As early as 2005, Marx reported a 
number of co-factors that were observed in patients who developed MRONJ, including tooth 
extraction, advanced periodontitis, abscessed teeth, root canal therapy and dental caries, all of 
which have microbial etiology (Marx et al., 2005). Since then, we and others have shown that 
dental infection combined with antiresorptive therapy is sufficient to induce murine 
osteonecrosis in both tooth extraction and non-extraction models (Aghaloo et al., 2011; Cheong 
et al., 2014; Song et al., 2016; Kim et al., 2018). Adult teeth are typically extracted when the 
tooth supporting structures are deficient or if the tooth itself is irreparably damaged, and in 
Chapter 2 we explore how the duration of periodontal inflammation influences the development 
of osteonecrosis.  
Altered Immune Response 
The immune system is a critical factor in bone loss and bone regulation, and there is continued 
debate on the role of innate and adaptive immunity in MRONJ pathogenesis. αβ-T cells are well 
known to direct pathologic bone loss, but recent studies have shown that a small population of T 
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cells with the γδ-T cell receptor produce factors that inhibit osteoclast formation and resorptive 
activity in vitro (Pappalardo and Thompson, 2013). Interestingly, this population of γδ-T cells is 
lost in patients taking bisphosphonates, suggesting a possible role for these cells in helping to 
reduce disease occurrence (Kalyan et al., 2013). Another study reported slightly more 
osteonecrosis development in BP-treated wild-type animals compared to γδ-T cell null mice and 
noted enhanced wound closure by γδ-T cell null mice, suggesting that γδ-T cells may contribute 
to oral mucosal healing but are unlikely to influence the development of osteonecrosis (Park et 
al., 2015). In addition to specific cell types that may affect MRONJ pathogenesis, an individual’s 
immune resiliency may determine whether they develop pathology. A group studying MRONJ 
patients observed a striking correlation between expression of genes related to immune and 
stress resiliency in peripheral blood leukocytes (including RANK, TNF-α and aryl hydrocarbon 
receptor) and the oral microbiome composition, which suggests that the microbiome may 
contribute to host response during MRONJ development (Kalyan et al., 2015), and in Chapter 3 
we isolate the role of the commensal microbiota in the development of bone necrosis. 
Soft Tissue Toxicity 
Prior to the development of α-RANKL antibodies, several groups were interested in the effects 
of BPs on soft tissue on the basis that some BP may reach the connective tissue or epithelium 
either from BP ingestion or release of BP during osteoclastic resorption. Indeed, BPs proved to 
be significantly toxic to cervical, prostate, and oral epithelial cells (Giraudo et al., 2004; Reid et 
al., 2007; Kim et al., 2011). However, the specificity of the antibody-based antiresorptive 
treatments and lack of soft tissue toxicity associated with α-RANKL antibody treatment is 
compelling evidence that toxicity by BPs may modify disease progression but does not drive it.  
Angiogenesis Inhibition  
A key physiologic feature of necrosis in most tissue types is a lack of blood supply, and an off-
target effect of BPs is a reduction in circulating vascular endothelial growth factor which reduces 
angiogenesis (Wood et al., 2002). Interestingly, the only other class of drugs known to cause 
 12 
 
MRONJ are anti-angiogenic agents such as vascular endothelial growth factor inhibitors and 
tyrosine kinase inhibitors (Estilo et al., 2008; Nicolatou-Galitis et al., 2012). While these drugs 
are targeted monoclonal antibodies, as a class they have significant untargeted effects on bone 
metabolism (Alemán et al., 2014). However, normal vasculature was observed in post-mortem 
MRONJ samples (Hellstein et al., 2011) and α-RANKL antibody treatment has not been 
associated with vascular changes (Misso et al., 2012). It is likely that angiogenesis inhibition 
contributes to disease pathogenesis but does not directly cause it.  
MRONJ and Periodontal Disease  
Periodontitis is one of the most prevalent oral infectious diseases, affecting nearly 50% of the 
adult population in the United States (Eke et al., 2012; Eke et al., 2015). The connection 
between periodontitis and MRONJ comes from observational studies, the first of which identified 
that 84% of patients with clinical MRONJ also suffered from periodontal disease (Marx et al., 
2005). Since then, a number of clinical (Boonyapakorn et al., 2008; Ruggiero et al., 2014; 
Thumbigere-Math et al., 2014) and pre-clinical studies (Aghaloo et al., 2011; Cheong et al., 
2014; Song et al., 2016; Kim et al., 2018) have confirmed that periodontal disease is a bona fide 
risk factor for the development of MRONJ. As mentioned in the Periodontitis section above, we 
utilize the ligature-induced periodontitis (LIP) model to induce local disease that mimics clinical 
periodontitis in mice. It is clear from our previous studies that necrotic bone formation is 
increased in diseased teeth following antiresorptive treatment, yet some animals still fail to 
develop bone necrosis. It is therefore critical to understand the mechanism by which periodontal 
disease and antiresorptive therapies modify the bone resorption process to enhance necrotic 
bone formation. In Chapter 2, we investigate and compare the effect of short-term (3 weeks) 
and long-term (10 weeks) LIP on histologic osteonecrosis, innate and adaptive immune 
recruitment, and local microbiota composition. 
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MRONJ and the Oral Microbiota 
The extensive body of research that suggested a strong correlation between infectious oral 
diseases and MRONJ has sparked interest in the potential role of specific pathobionts in 
osteonecrosis development. A variety of microbial species have been identified from colonies 
found on excised human MRONJ lesions using scanning electron microscopy (Sedghizadeh et 
al., 2008) and metagenomic analysis (Pushalkar et al., 2014; Kalyan et al., 2015). Although 
metagenomic analysis has not consistently revealed an abundance of a particular species, 
increased Actinomyces spp. accumulation on MRONJ lesions has been reported multiple times 
(Marx et al., 2005; Kaplan et al., 2009; Kos et al., 2010). Moreover, a critical role for bacterial 
infections in MRONJ pathogenesis has been elucidated by studies showing a decrease in ONJ 
incidence in cancer patients who improved their oral hygiene (Ripamonti et al., 2009).  
Inhibited bone resorption is a central feature in MRONJ development, as osteonecrosis does 
not occur after treatment with anabolic agents (Hadaya et al., 2019). Interestingly, the 
commensal microbiota has recently been shown to exert a catabolic effect on bone mass, the 
mechanism by which is currently under active investigation, but the net effect is increased bone 
mass in the absence of bacteria (Sjögren et al., 2012; Novince et al., 2017). Additionally, the 
recommended treatment for MRONJ involves systemic and oral antibiotic treatment in order to 
reduce infections that may exacerbate symptoms (Ruggiero et al., 2014). Given how critical 
bone remodeling is during MRONJ pathogenesis, Chapter 3 examines the role of the 
commensal microbiota in osteonecrosis development following significant reduction in local 
microbe populations by antibiotic treatment.  
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Aims 
Although the research community has been aware of MRONJ for the past 15 years, there are 
no targeted treatment methods for MRONJ nor are there reliable detection methods for 
identifying patients at the highest risk for MRONJ because the exact etiology of the condition is 
still unclear. The objective of this work was to understand MRONJ pathophysiology in the 
context of inflammation. In order to do so, we characterized the role of periodontal inflammation 
and the commensal microbiota on MRONJ pathogenesis.   
Aim 1: To investigate the effect of long-term LIP on MRONJ pathogenesis.  We examined local 
and systemic differences in bone loss and cytokine expression, respectively, in short-term LIP 
(S-LIP) and long-term (L-LIP) mouse models. We also utilized 16S sequencing to determine 
changes in alpha and beta diversity of oral microbiota in S-LIP and L-LIP. Finally, we combined 
S-LIP and L-LIP with BP treatment and assessed local histologic markers of MRONJ. This work 
is outlined in Chapter 2 and has not been published.   
Aim 2: To determine the etiologic role of the oral microbiota in MRONJ development. We 
established a “germ-reduced” mouse model using broad spectrum antibiotic oral gavage. We 
determined whether empty lacunae and necrotic bone are altered at the site of tooth extraction 
in germ-reduced compared to antibiotic-naïve mice treated with BP. We assessed the role of the 
commensal microbiota in the pathologic bone loss seen in S-LIP. Finally, we assessed the role 
of the microbiota in inflammation induced MRONJ. This work is outlined in Chapter 3 and has 
not been published. 
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Long-term ligature-induced periodontitis exacerbates MRONJ development in mice* 
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Abstract 
Medication-related osteonecrosis of the jaw (MRONJ) is a detrimental intraoral lesion that 
occurs in patients with long-term or high-dose use of anti-resorptive agents such as 
bisphosphonates (BP). Tooth extractions are known risk factors for MRONJ, and these 
interventions are often performed to eliminate existing pathological inflammatory conditions. 
Previously, we determined that ligature-induced periodontitis (LIP) is a risk factor for MRONJ, 
but it remains unclear whether the chronicity of LIP influences MRONJ development. In this 
study, we assess the effect of LIP (for 3 or 10 weeks) on MRONJ development. We analyzed 
alveolar bone loss in maxillae using μCT. We harvested maxillary oral mucosal tissue and 
analyzed pro- and anti-inflammatory cytokine expression by quantitative real-time PCR. 
Systemic pro-inflammatory cytokine levels were assessed by ELISA. Hallmarks of ONJ, innate 
and adaptive immune populations were quantified from histologic sections. Although systemic 
BP treatment prevented alveolar bone loss induced by 10-week ligature placement, when a 
diseased tooth was extracted in mice with BP administration, histologic hallmarks of MRONJ 
including empty lacunae and necrotic bone increased compared to the group receiving BP and 
extraction of a healthy tooth.  We also observed significant increases in PF4 and MIP1γ in mice 
that received BP treatment and had tooth extractions compared to controls. Additionally, we 
identify CD3+ T cells as the major immune population in both health and disease and observe a 
significant increase in CD4+IL23R+ T cells in MRONJ-like lesions. Taken together, our study 
reveals that extracting a periodontally compromised tooth increases the formation of necrotic 
bone compared to extracting a periodontally healthy tooth.  
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Introduction 
Antiresorptive therapy with bisphosphonates such as zoledronic acid (ZOL) is the current front-
line therapy for bone degenerative diseases such as osteoporosis (Compston et al., 2019).  
Additionally, bisphosphonates are becoming an increasingly important tool in reducing bone 
pain and skeletal related events in metastatic bone disease (Neville-Webbe and Coleman, 
2010). Nitrogen containing bisphosphonates including ZOL act by inhibiting post-translational 
prenylation of proteins critical for osteoclast function, ultimately leading to osteoclast apoptosis 
and inhibition of osteoclast-mediated bone resorption (Roelofs et al., 2006).  
A rare but detrimental side effect of bisphosphonates is the development of medication related 
osteonecrosis of the jaw (MRONJ), which often occurs at the site of a tooth extraction or 
invasive dental surgery (Kennel and Drake, 2009). The pathophysiology of MRONJ has been 
extensively studied since the first report in 2003 (Marx, 2003) but remains elusive to date 
(Aghaloo et al., 2015). Notable current hypotheses to explain MRONJ development include 
bone remodeling inhibition (Williams et al., 2014), inflammation and infection (Aghaloo et al., 
2011; Kim et al., 2018), angiogenesis inhibition (Lescaille et al., 2014), soft tissue toxicity (Kim 
et al., 2011), and innate or acquired immune dysfunction (Kikuiri et al., 2010).  
While several risk factors for MRONJ development have been reported in the literature, many 
reported MRONJ cases occur following the extraction of a tooth with local pathologic 
inflammation (Thumbigere-Math et al., 2014). This clinical observation has been corroborated in 
several animal models of periodontal and periapical disease with concomitant antiresorptive 
treatment and tooth extraction (Song et al., 2016; Kim et al., 2018; Aghaloo et al., 2011; 
Soundia et al., 2018). These studies have established that localized periodontal inflammation is 
a bona fide risk factor for MRONJ development.  
Periodontal inflammation increases necrotic bone formation compared to antiresorptive 
treatment alone in animal studies. Thus, advancing our understanding of how periodontal 
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inflammation leads to an increase in necrotic bone formation during antiresorptive treatment is 
of critical clinical importance. In the following study, we investigate and compare the effect of 
short-term (3 weeks) and long-term (10 weeks) ligature induced periodontitis (S-LIP and L-LIP, 
respectively) on histologic osteonecrosis, innate and adaptive immune recruitment, and local 
microbiota composition.  
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Materials and Methods 
Animals 
6-week-old female C57BL/6J mice were purchased from the Jackson Laboratories and housed 
in a specific pathogen free environment with 12-hour light/dark cycle managed by the UCLA 
Division of Laboratory and Animal Medicine. All experimental protocols were approved by 
institutional guidelines from the Chancellor’s Animal Research Committee (2011-062).  
Ligature-induced periodontitis mouse models 
We have modified our previously established mouse model for MRONJ (Williams et al., 2014) to 
include varying times of ligature-induced inflammation preceding the tooth extraction and 
healing phase. To summarize, mice were subjected to either short- or long-term (3 or 10 weeks, 
respectively) ligature-induced periodontitis (LIP) without any anti-resorptive intervention (Figure 
1A), where a 6-0 suture was placed around the second maxillary molar (M2) under general 
anesthesia as described previously (Kim et al., 2018). A separate cohort of mice were subjected 
to long-term LIP (L-LIP) while undergoing biweekly intravenous infusions of 0.9% NaCl (Veh) or 
Zoledronic Acid (ZOL; 125μg/kg; Sagent Pharmaceuticals) (Figure 3A). A third cohort of mice 
underwent L-LIP and ZOL treatment followed by M2 extraction and healing for three weeks 
(Figure 4A). A final cohort of mice underwent either short-term LIP (S-LIP) or L-LIP and ZOL 
treatment followed by M2 extraction and healing for three weeks (Appendix Figure 5A).  
Micro-computed tomography and bone loss analysis 
Whole maxillae were scanned with a voxel size of 10μm3 using a 1.0 mm aluminum filter at 60 
kVp and 166μA (SkyScan 1275; Bruker). Other scanning parameters include rotation step of 0.4 
degrees, frame averaging of 6 and random movement. 2-dimensional images were 
reconstructed using N Recon (Bruker) following X-Y alignment and dynamic range adjustment. 
Reconstructed images were saved as 16-bit TIFF images and used for bone loss analysis. Bone 
loss was quantified by measuring the distance between cementoenamel junction and the 
alveolar ridge on the palatal, mesiobuccal and distobuccal roots of M2 using CTAn (Bruker). 3-
dimensional representative images were generated in CTVox (Bruker).  
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Histomorphometric and histochemical staining 
We evaluated histologic signs of MRONJ lesions by hematoxylin and eosin staining following 
decalcification and paraffin embedding as described previously without modification (Williams et 
al., 2014). We determined the number of Tartrate-resistant acid phosphatase-positive 
osteoclasts around the M2 region with a kit according to the manufacturer’s protocol (#387A-
1KT, Millipore Sigma).  
Immunofluorescence staining 
Formalin fixed paraffin embedded tissues were rehydrated by serial dilutions of xylene and 
ethanol. Antigen retrieval in citrate buffer was carried out at 60°C overnight. Sections were 
blocked in 10% normal goat serum and incubated in primary antibody diluted in 3% serum 
overnight at 4°C. Primary antibodies included CD3 (#ab5690, Abcam), CD19 (#ab25232, 
Abcam), CD66b (#ab197678, Abcam), F4/80 (#MCA497GA, Bio-Rad), CD4 (#12-0041-83, 
Thermofisher Scientific), and IL23R (#ab53656, Abcam). After washing, secondary antibody 
diluted in 3% serum was incubated for 1 hour followed by DAPI counterstain for 8 minutes. 
Slides were mounted using Prolong Gold (P36930; Thermofisher Scientific) and imaged with a 
confocal microscope (LSM700; Zeiss).   
Multiplexed sandwich ELISA Array 
We assayed sera from S-LIP and L-LIP animals with and without ZOL treatment to determine 
changes in 40 different pro-inflammatory cytokines following the manufacturer’s protocol 
(#QAM-CYT-5; RayBiotech). Glass slides were imaged by RayBiotech and raw data was 
extracted and analyzed in Excel.  
Quantitative real-time PCR 
To assess local changes in inflammatory cytokines, palatal tissues immediately adjacent to the 
ligated M2 were processed to obtain RNA as described and cDNA using qScript cDNA 
SuperMix following manufacturer’s protocol (#101414-108; VWR). Gene expression was 
assessed using PowerUp SYBR Green Master Mix (#100029284; Applied Biosystems) in a 
QuantStudio 3 Real-Time PCR System (Applied Biosystems). Fold differences between 
 27 
 
samples were calculated with the ΔΔCt method using 18S as the housekeeping gene. Primer 
sequences can be found in Table 1. 
Table 1. List of primers 
Gene Forward (5'-3') Reverse (5'-3') Specie
s 
18S GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG Mouse 
Tnf CCCTCACACTCAGATCATCTTC
T 
GCTACGACGTGGGCTACAG Mouse 
Il1b GCAACTGTTCCTGAACTCAACT ATCTTTTGGGGTCCGTCAACT Mouse 
Il6 TAGTCCTTCCTACCCCAATTTC
C 
TTGGTCCTTAGCCACTCCTTC Mouse 
Il10 GCTCTTACTGACTGGCATGAG CGCAGCTCTAGGAGCATGTG Mouse 
Tgfb1 CTCCCGTGGCTTCTAGTGC GCCTTAGTTTGGACAGGATCT
G 
Mouse 
Igf1 CTGGACCAGAGACCCTTTGC GGACGGGGACTTCTGAGTCTT Mouse 
Foxp3 CCCATCCCCAGGAGTCTTG ACCATGACTAGGGGCACTGTA Mouse 
Il17a TTTAACTCCCTTGGCGCAAAA CTTTCCCTCCGCATTGACAC Mouse 
Mmp9 ACGACATAGACGGCATCCA GCTGTGGTTCAGTTGTGGTG Mouse 
 
16S rRNA Sequencing 
Bacterial DNA was extracted from fecal, oral, spleen and liver samples as described above. 
Library preparation was performed as described (Tong et al., 2014) using uniquely barcoded 
primers targeting the V4 region of the 16S gene (Caporaso et al., 2012). Pooled libraries diluted 
to 6pM in 20% PhiX underwent paired-end (2x250bp) sequencing using the Illumina MiSeq v2 
platform. Demultiplexed sequencing results were analyzed with the QIIME pipeline (Caporaso et 
al., 2010). 
Statistical Analysis 
All data are shown as mean ± SEM. For all figures, differences between groups were compared 
by one- or two-way ANOVA with Tukey’s post-hoc test, as appropriate.  *p < 0.05; **p < 0.01; 
***p < 0.001; ****p < 0.0001; ns, not statistically significant.  
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Results 
Long-term ligature placement exacerbates bone loss and pro-inflammatory cytokine 
expression 
To determine the effect of prolonged ligature treatment in mice, we compared local 
consequences of S-LIP and L-LIP (Fig. 1A). Gross photographic examination revealed an 
increase in blanched areas surrounding L-LIP sites compared to S-LIP and no-ligature control 
(NLC) sites (Appendix Fig. 1A). μCT analysis showed a marked increase in the area of bone 
resorption at L-LIP sites compared to S-LIP (Appendix Fig. 1B). As previously reported, 
cemento-enamel junction (CEJ) to alveolar bone crest (ABC) distance was significantly 
increased in S-LIP compared to NLC sites (Kim et al., 2018), but L-LIP resulted in even further 
CEJ-ABC distance compared to S-LIP (Fig. 1B-C). Histologic analysis revealed increased 
inflammatory infiltrate and bone loss at the site of ligature placement that was accompanied by 
a significant increase in osteoclast number (Fig. 1D-E, Appendix Fig. 1C). No changes were 
observed in bone loss, osteoclast number, or gross histology between NLC sites in S-LIP and L-
LIP, so all NLC samples were combined during analysis. Previous reports have suggested that 
ligature placement elicits a systemic immune response that is both gender and time dependent 
(Bain et al., 2009; Saadi-Thiers et al., 2013), so we assessed pro-inflammatory cytokine 
expression in serum using a multiplex cytokine array. We observed a non-statistically significant 
increase in cytokines such as IL1β, IL6, and IL17 in LIP groups compared to the control, but no 
differences were observed in a time-dependent manner (Appendix Fig. 2). In contrast, 
chemokines PF4 and MIP1γ were significantly increased after ligature treatment compared to 
controls (Fig. 1F). Liver Igf1 and Tgf-β increased in a time-dependent manner, whereas in the 
gingiva, only Il17a expression was significantly increased in L-LIP animals compared to S-LIP 
and NLC groups (Fig 1G, Appendix Fig. 1D-F). Together, this proof-of-concept animal model 
establishes a clear difference in bone loss and cyto/chemokine expression in short- and long-
term LIP.  
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Figure 1. Phenotypic characterization of short- and long-term ligature induced periodontitis.  
A. Visual representation of the experimental timeline. Briefly, 8-week-old C57BL/6J mice were split into two groups. 
The first group received no treatment for 7 weeks, and then a 6-0 silk suture was tied around the second maxillary 
molar. The second group received the suture for 10 weeks. B. Saggital view of μCT scanned and reconstructed 
maxilla depicting buccal bone loss at ligature and no-ligature control sites in S-LIP and L-LIP mice. No differences 
were seen between NLC from S-LIP and L-LIP samples, so these sites were combined into a single ‘NLC’ group for 
analysis. C. Quantification of bone loss at each of the second maxillary molar roots. D. TRAP staining on coronal 
histologic sections at the site of ligation. Tooth (T) and ligature (L) are labeled for reference. Bar: 100μm. E. 
Quantification of TRAP-positive multinucleated osteoclasts at the site of ligature placement. F. Serum analysis of pro-
inflammatory cytokine array targets platelet factor 4 (PF-4) and macrophage inflammatory factor 1 gamma (MIP-1γ). 
G. Quantitative real-time PCR of gingival tissue taken from ligature or no-ligature control sites. S-LIP, short-term 
ligature-induced periodontitis (3 weeks); L-LIP, long-term ligature-induced periodontitis (10 weeks), NLC, no-ligature 
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control; MB, mesio-buccal; DB, disto-buccal; L (root), lingual; N.Oc/B.Ar, number of osteoclasts per bone area. 
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. Data is presented as mean ± SEM.  
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Host response drives pathologic bone loss in L-LIP  
In the LIP mouse model, the ligature supports microbe aggregation at the dentogingival junction 
which enables microbe invasion into the connective tissue (Graves et al., 2012). Given the 
significant differences in pathologies between S-LIP and L-LIP, we aimed to understand 
whether this was due to altered microbe composition on the ligature or an extended host 
response to inflammation. 16S sequencing revealed significantly reduced alpha and beta 
diversity at the amplicon sequence variant level on S- and L-LIP ligatures compared to controls, 
but no differences were seen in diversity metrics between S-LIP and L-LIP alone (Fig. 2A-C), 
suggesting that there are no differences between the number and type of microbes on LIP 
ligatures after 3 or 10 weeks. To understand how differences in the length of ligature placement 
affect local immune responses, we stained coronal sections at the site of ligature placement 
with surface markers for T cells, B cells, tissue resident macrophages and granulocytes (Fig. 
2D, Appendix Fig. 3). Both CD3+ T cells and F4/80+ macrophages significantly increased in a 
time dependent manner, whereas CD66b+ granulocytes increased in S-LIP but not in L-LIP 
(Fig. 2E). CD19+ B cells were undetected in the samples tested (not shown). The total number 
of immune cells per treatment condition were tallied to reveal that CD3+ T cells were the 
dominant immune cell in both health and disease (Fig. 2F). These data suggest that host 
response rather than microbiota composition is primarily responsible for pathologic bone loss 
seen in LIP.   
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Figure 2. Host response drives pathologic bone loss in LIP.  
A,B. The alpha (A) and beta (B) diversity of the microbial communities found at the site of ligature placement were 
calculated by Faith’s phylogenetic diversity and Bray-Curtis dissimilarity principal component analysis, respectively. 
C. Microbiome composition is shown at the amplicon sequence variant level (ASV). The top 23 ASVs are classified at 
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the highest taxonomic level identified. s_, species; g_, genus; f_, family. D-F. Representative images and 
quantification of immunofluorescent staining at the site of ligature placement. The total number of cells (E) were 
counted and the proportion of each cell type present was tallied (F). Scale bar: 50μm. S-LIP, short-term ligature-
induced periodontitis (3 weeks); L-LIP, long-term ligature-induced periodontitis (10 weeks), NLC, no-ligature control; 
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. Data is presented as mean ± SEM.  
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L-LIP and BP treatment in combination induce osteonecrosis in mice 
Although clinical MRONJ typically occurs after a tooth extraction or dental surgery, rat studies 
have suggested that osteonecrosis develops in the presence of periodontal disease without 
tooth extraction (Aghaloo et al., 2011; Li et al., 2016). To determine the effect of concomitant L-
LIP and BP treatment on bone resorption and osteonecrosis development we treated a cohort of 
mice with combinations of L-LIP and/or BP (Fig. 3A). Gross examination of maxillae after 10 
weeks revealed significant epithelial recession at vehicle (Veh) treated LIP sites that was not 
present in BP treated LIP or NLC sites (Appendix Fig. 4A, left). μCT analysis showed a 
marked reduction in the palatal extent of bone resorption at L-LIP/ZOL sites compared to L-
LIP/Veh sites (Appendix Fig. 4A, right, black arrowheads). Sagittal views of μCT 
reconstructions demonstrated the efficacy of ZOL at inhibiting L-LIP-induced alveolar bone 
resorption (Fig 3B,C). Although we observed no significant difference in bone loss between L-
LIP/ZOL and NLC animals, the bone immediately adjacent to the ligature site had a unique 
appearance compared to NLC sites (Fig 3B, white arrowheads). Histologic analysis confirmed 
that the buccal bone directly adjacent to the ligature site was necrotic, and necrosis was only 
seen in the L-LIP/ZOL cohort (Fig 3D,E). L-LIP treatment resulted in a significant increase in the 
number of TRAP+ osteoclasts regardless of antiresorptive therapy (Fig 3F,G). This data 
cumulatively suggests that osteonecrosis develops independently of tooth extractions in mice 
following L-LIP treatment.  
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Figure 3. Long-term ligature and anti-resorptive therapy leads to extraction-independent osteonecrosis.  
A. 8-week-old C57BL/6 mice were split into two groups. These groups received biweekly intravenous injections of 
vehicle or zoledronic acid for the entire study. After one week of infusions, half of the mice in each group received a 
suture as described in Figure 1A for 10 weeks. B. Saggital view of μCT scanned and reconstructed maxilla depicting 
buccal bone loss. White arrowheads point to necrotic bone at the site of ligature placement visible by μCT. C. 
Quantification of bone loss at each of the second maxillary molar roots. D. Hematoxylin & Eosin staining on coronal 
histologic sections at the site of ligation. Tooth (T) and ligature (L) are labeled for reference. Necrotic bone is outlined 
by the black dotted line. Scale bar: 100μm. E. Quantification of empty lacunae (left) and necrotic bone (right) from 
histology sections. F. TRAP staining on coronal histologic sections at the site of ligation. Tooth (T) and ligature (L) are 
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labeled for reference. Scale bar: 100μm. G. Quantification of TRAP-positive multinucleated osteoclasts at the site of 
ligature placement. Veh, vehicle; ZOL, zoledronic acid; NLC, no-ligature control; MB, mesio-buccal; DB, disto-buccal; 
P, palatal; N.Oc/B.Ar, number of osteoclasts per bone area. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. Data is 
presented as mean ± SEM.  
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L-LIP and ZOL induce osteonecrosis development in a tooth extraction mouse model 
In our non-extraction L-LIP/ZOL mouse model we observed significant osteonecrosis 
development in the L-LIP/ZOL group but none in the NLC/ZOL group (Fig 3B-E). To isolate the 
role of tooth extraction and L-LIP in osteonecrosis pathogenesis, we observed bone phenotypes 
in mice treated with BP and/or L-LIP, where the ligatured tooth was extracted and underwent 
healing for 3 weeks (Fig. 4A). Gross photograph and μCT showed significant inhibition of 
extraction socket resorption in ZOL treated animals (Appendix Fig. 4B). Like L-LIP/ZOL 
animals without extraction, L-LIP/ZOL with extraction resulted in significant buccal bone 
necrosis visible by both μCT and histology (Fig. 4B, white arrows, C-D). In line with previous 
findings (Williams et al., 2014; Kim et al., 2018) we observed moderate but significantly less 
osteonecrosis development in NLC/ZOL compared to L-LIP/ZOL mice (Fig. 4C-D). The number 
of TRAP+ osteoclasts increased in all groups compared to the control, and a trending increase 
was observed in the number of TRAP+ osteoclasts in NLC/ZOL and L-LIP/ZOL groups (Fig. 4E-
F). Cumulatively, this data shows the additive effect of ligature-induced inflammation and tooth 
extraction on osteonecrosis development in mice.  
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Figure 4. Long-term ligature and anti-resorptive therapy leads to post-extraction osteonecrosis.  
A. Mice were divided exactly as in Figure 3A. After 10 weeks of ligature, mice underwent bilateral second maxillary 
molar extractions and were allowed to heal for 3 weeks prior to sacrifice.B. Clinical (left) and μCT reconstructed 
photographs (transverse view, middle; saggital view, left) depicting soft tissue healing and extent of socket 
remodeling. White arrowheads point to necrotic bone at the second maxillary molar visible by μCT. B. Hematoxylin & 
Eosin staining on coronal histologic sections at the extraction site. Necrotic bone is outlined by the black dotted lines. 
Scale bar: 100μm. C. Quantification of empty lacunae (left) and necrotic bone (right) from histology sections. D. 
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TRAP staining on coronal histologic sections at the site of extraction. Scale bar: 100μm. E. Quantification of TRAP-
positive multinucleated osteoclasts at the site of extraction. Veh, vehicle; ZOL, zoledronic acid; NLC, no-ligature 
control; N.Oc/B.Ar, number of osteoclasts per bone area. *p<0.05; **p<0.01; ***p<0.001. Data is presented as mean 
± SEM.  
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Duration of ligature placement is associated with osteonecrosis development in mice 
Previous studies have universally identified periodontitis as an important risk factor for the 
development of osteonecrotic lesions in rodent models and in clinical studies. One caveat to the 
published rodent studies is that periodontal disease was not allowed to progress to a point 
where bone loss was substantial enough that would necessitate extraction. To determine 
whether the duration of ligature placement influences osteonecrosis development in mice, we 
assessed osteonecrosis development in L-LIP/ZOL and S-LIP/ZOL models (Appendix Fig. 5A). 
Although gross photographs showed similar patterns of epithelial closure between L-LIP and S-
LIP groups, μCT analysis confirmed that the bony sequestrum seen in previous L-LIP/ZOL 
studies was unique to the L-LIP group (Fig 5A). Histologic analysis revealed that empty lacunae 
and percent bone necrosis increased in a ligature duration-dependent manner (Fig 5B-C). In 
contrast to short- and long-term periodontitis models, serum levels of MIP1γ and PF4 increased 
in a time-dependent manner (Fig 5D). We previously found that CD3+ T cell counts increased 
following LIP in a time-dependent manner (Fig. 2D-F). Th17 cells are a subset of CD3+ T cells 
and drive the pathologic bone loss in periodontal disease (Dutzan et al., 2018) and have been 
implicated in a multiple myeloma model of MRONJ (Zhang et al., 2013). We quantified 
CD4+IL23R+ cells at the site of ligature placement and found significantly increased numbers in 
both S-LIP and L-LIP/ZOL samples compared to Veh controls. Interestingly, the increase in 
CD4+IL23R+ was confined to S-LIP and L-LIP/ZOL samples that had incomplete epithelial 
closure in addition to necrotic bone (Fig. 5E-F). Together, these findings suggest that duration 
of periodontal inflammation is critical in MRONJ pathogenesis. 
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Figure 5. Osteonecrosis development is dependent on duration of ligature-induced periodontitis.  
A. Clinical (left) and μCT (right) reconstructed photographs depicting epithelial and osseous healing following 
extraction. Black arrowheads show exposed bone with incomplete epithelial closure. White arrowhead points to 
necrotic bone at the site of extraction visible by μCT. B. Hematoxylin & Eosin staining on coronal histologic sections 
at the site of tooth extraction. Necrotic bone is outlined by the black dotted lines. Scale bar: 100μm. C. Quantification 
of empty lacunae (left) and necrotic bone (right) from histology sections. D. Serum analysis of pro-inflammatory 
cytokine array targets platelet factor 4 (PF-4) and macrophage inflammatory factor 1 gamma (MIP-1γ). E,F. 
Representative images and quantification of dual labeled immunofluorescent staining colocalized to DAPI at the site 
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of extraction. Scale bar: 50μm. G,H. Summary illustration of findings. (G) In L-LIP, the number of osteoclasts and 
CD3+ T cells is increased compared to S-LIP, but the number and type of bacteria is the same. (H) When LIP is 
combined with antiresorptive therapy and extraction, the amount of necrotic bone and number of CD4+IL23R+ T cells 
is increased in L-LIP compared to S-LIP. Veh, vehicle; ZOL, zoledronic acid; S-LIP, short-term ligature-induced 
periodontitis; L-LIP, long-term ligature-induced periodontitis; EC, epithelial closure. *p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001. Data is presented as mean ± SEM. 
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Discussion 
In this study, we identify phenotypic characteristics of S-LIP and L-LIP mouse models 
including differences in alveolar bone loss, osteoclast number, local and systemic expression of 
pro-inflammatory cytokines, microbiome, and local immune cell populations (Fig. 1,2). We show 
that osteonecrosis develops independently of tooth extractions in the L-LIP model combined 
with zoledronic acid treatment and consistently forms necrotic bone that is visible by μCT (Fig. 
3,4,5A). Additionally, we show that the duration of local periodontal inflammation is an important 
factor in osteonecrosis development, potentially due to heightened Th17 cell recruitment (Fig. 
5). 
Although many confounding variables including genetic background, anti-resorptive 
dose, age, and others are controlled in animal models of MRONJ, only a percentage of animals 
develop MRONJ-like lesions. It is therefore critical to develop models that consistently produce 
the MRONJ-like phenotype in order to minimize the number animals required to obtain relevant 
results. By inducing long-term inflammation, we have developed a model where almost all 
animals consistently develop some level of osteonecrosis while at the same time maintaining 
clinically relevant doses of ZOL (Fig. 5). Moreover, our L-LIP treatment results in significant 
bone loss (Fig. 1C), to the point where tooth prognosis is severely compromised which closely 
mimics a clinical situation that would warrant extraction. 
A cytokine array assay detected significantly increased levels of PF4 in S-LIP and L-LIP 
(Fig. 1F).  PF4 is stored within platelet α-granules and is released upon inflammation-induced 
platelet activation (Harrison and Cramer, 1993). A link between platelet activity and periodontitis 
has been established (Papapanagiotou et al., 2009; Nicu et al., 2009; Al-Rasheed, 2012) and 
studies have shown increased soluble PF4 in gingival crevicular fluid and serum of patients with 
severe periodontitis (Greinacher et al., 2011; Brousseau-Nault et al., 2017), suggesting that PF4 
may be a biomarker of advanced periodontal disease. PF4 is degraded by matrix 
metalloproteinase 9 (MMP9) (Van den Steen et al., 2000), which is inhibited by 
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bisphosphonates like ZOL (Teronen et al., 1999). Assessment of PF4 in our mouse model of L-
LIP combined with ZOL therapy and tooth extraction revealed a time-dependent increase in PF4 
levels (Fig. 5D), presumably due to decreased MMP9-mediated degradation by ZOL. We 
speculate that PF4 may be used to identify patients taking bisphosphonates that have advanced 
periodontal disease and are therefore at high risk for developing MRONJ.  
Maintenance of barrier integrity is critical for host survival, and this is especially 
important during periodontal infection and following dentoalveolar surgery. The role of the oral 
microbiota in MRONJ pathogenesis remains controversial, although a recent study identified 
that there were no apparent differences in the microbial populations of MRONJ patients 
compared to healthy controls (Kalyan et al., 2015). Instead, the patients who developed MRONJ 
had significantly reduced expression of genes that regulate immune and barrier function. The 
dominating immune population in both health and periodontal disease are CD3+ T cells (Fig. 2F, 
(Dutzan et al., 2016). Interestingly, the number of CD4+IL23R+ T cells is significantly higher at 
the extraction site in S-LIP and L-LIP mice treated with ZOL compared to Veh controls, and 
increases with longer ligature placement periods (Fig. 5F). Interestingly, the length of ligature 
placement did not alter the number or type of microbes that colonized the ligature (Fig. 2A-C), 
suggesting that host response to inflammation plays a larger role than microbiota composition in 
pathologic bone loss and osteonecrosis development in our mouse model. Overall, further 
studies are warranted to determine the exact role of T cells in MRONJ pathogenesis.  
In summary, we have established and characterized a mouse model of long-term 
ligature-induced inflammation that leads to the development of osteonecrosis in mice. We have 
identified that the duration of inflammation is associated with the amount of necrotic bone 
formation following tooth extraction in mice receiving ZOL infusions. Our study also provides 
evidence to support clinical guidelines that prioritize the resolution of pathologic inflammatory 
conditions in ZOL users to reduce the likelihood of MRONJ development. 
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Appendix Figure 1.  
A. Clinical photograph depicting ligature and no-ligature control sites in S-LIP and L-LIP mice. White dotted lines 
depict extent of tissue blanching caused by ligature placement. B. Transverse view of μCT scanned and 
reconstructed maxilla. Black arrowheads indicate extent of resorption caused by ligature placement. C. Hematoxylin 
& Eosin staining on coronal histologic sections at the site of ligation showing inflammatory infiltrate at the site of 
ligature placement. Tooth (T) and ligature (L) are labeled for reference. Bar: 100μm. D-F. Quantitative real-time PCR 
of spleen (D), liver (E), and gingival tissue taken from ligature or no-ligature control sites (F). S-LIP, short-term 
ligature-induced periodontitis (3 weeks); L-LIP, long-term ligature-induced periodontitis (10 weeks), NLC, no-ligature 
control. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. Data is presented as mean ± SEM.  
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Appendix Figure 2.  
Serum analysis of pro-inflammatory cytokine array targets are shown. Targets are separated by general function 
including pro-inflammatory cytokines (A), chemokines (B), anti-inflammatory cytokines (C), and growth factors (D). 
*p<0.05; ***p<0.001; ****p<0.0001.  
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Appendix Figure 3.  
A,B. Individual channels of the merged image in Figure 2D are shown. S-LIP, short-term ligature-induced periodontitis 
(3 weeks); L-LIP, long-term ligature-induced periodontitis (10 weeks), NLC, no-ligature control. Scale bar: 50μm.  
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Appendix Figure 4.  
A. Clinical (left) and μCT reconstructed photographs (right) depicting extent of tissue blanching caused by ligature 
placement and extent of palatal bone resorption (black arrowheads) in a model of L-LIP without tooth extraction. B. 
Clinical (left) and μCT reconstructed photographs (right) depicting oral mucosal healing and extent of palatal bone 
resorption (black arrowheads) in a model of L-LIP with tooth extraction. 
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Appendix Figure 5.  
A. In Figure 5, the mouse model in Figure 4A was directly compared to our previously published mouse model, where 
we induce periodontitis by ligature for 3 weeks in zoledronic acid treated mice, extract the ligated tooth and allow for 3 
weeks of healing. B. Individual channels of the merged image in Figure 5E are shown. S-LIP, short-term ligature-
induced periodontitis (3 weeks); L-LIP, long-term ligature-induced periodontitis (10 weeks); ZOL, zoledronic acid; EC, 
epithelial closure. Scale bar: 50μm. 
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Commensal microbiota protects against inflammation-induced osteonecrosis following 
zoledronic acid infusion* 
 
 
 
 
 
 
 
 
 
*In preparation for publication 
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Abstract 
Medication-related osteonecrosis of the jaw (MRONJ) is a rare intraoral lesion that occurs in 
patients with long-term and/or high-dose use of nitrogen-containing bisphosphonates such as 
zoledronic acid (ZOL). Previously, several studies have found increased microbial signatures 
present on human MRONJ lesion biopsies, but the role of the commensal microbiota in MRONJ 
pathogenesis is unknown. Here, we examined the role of the commensal microbiota in MRONJ 
development following extraction of healthy teeth and teeth with ligature-induced periodontitis 
(LIP). In support of previous findings, we show increased bacterial infiltration in MRONJ lesions 
compared to normal healed controls. We found that antibiotic-mediated oral dysbiosis leads to a 
local inhibition of bone resorption in the context of LIP. In our MRONJ model, antibiotic-treated 
animals (Abx) displayed distended ceca, involuted spleens, and significantly reduced oral and 
fecal bacterial loads compared to the specific-pathogen free (SPF) cohort. We observed no 
significant difference in empty lacunae, necrotic bone formation, osteoclast number and surface 
area in Abx and SPF animals following extraction of healthy teeth. However, extraction of LIP-
teeth led to increased empty lacunae, necrotic bone, and osteoclast surface area in Abx 
compared to SPF mice. Our findings suggest that the commensal microbiome protects against 
LIP-induced osteonecrosis. 
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Introduction 
Antiresorptive therapies (ART) including nitrogen-containing bisphosphonates like Zoledronic 
Acid (ZOL) are the first-line treatment of choice for osteoporosis treatment and critical in the 
prevention of skeletal metastases in cancer patients(Chen and Sambrook, 2011). Medication-
related osteonecrosis of the jaw (MRONJ) is a rare but serious oral complication that typically 
occurs following dental interventions in patients taking ART for prolonged periods of time or at 
high doses(Marx et al., 2007). MRONJ is clinically defined as exposed bone that has persisted 
for over 8 weeks in patients who have no history of radiation exposure to the head and neck 
area(Ruggiero et al., 2014) but have been exposed to ART.  
The barrier mucosal organs contain a robust epithelium that uniquely separates two contending 
cell populations: a diverse community of microorganisms that exert pleiotropic effects on host 
function(Shreiner et al., 2015); and a mixture of host immune, endothelial, and mesenchymal 
cells that form intricate networks for nutrient and antigen exchange (Chang et al., 2014). The 
coevolution of host and microbiota has resulted in a delicate and mutually beneficial system 
whereby the host provides microbes a niche with abundant carbon sources, and the microbes 
aid in digestion of complex carbohydrates (Flint et al., 2012). Unlike other barrier mucosal 
tissues, the oral cavity contains trans-mucosal organs (teeth) that lack tight junctions at their 
interface with the oral mucosa, making this area particularly susceptible to bacterial infiltration 
(Bosshardt and Lang, 2005). When commensal bacteria accumulate at sites directly adjacent to 
this interface they can become pathobionts that cause local inflammation leading to a host-
mediated destruction of alveolar bone, clinically known as periodontitis (Darveau, 2010).  
In early reports of MRONJ, 84% of patients had periodontal disease as a dental comorbidity and 
in 78% of the cases, the precipitating event that led to ONJ development was an extraction or 
dental surgery (Marx et al., 2005) which has been corroborated in vivo (Kim et al., 2018; 
Soundia et al., 2018; Aghaloo et al., 2011). Because periodontal disease is driven by local 
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microbial dysbiosis and extraction sites are in intimate contact with oral bacteria during healing, 
several groups have investigated the association between the oral microbiome and MRONJ 
lesion development. Scanning electron microscope analysis from MRONJ lesions has revealed 
microbial biofilm formation on sequestered bone (Sedghizadeh et al., 2008). Metagenomic 
analyses have been varied with respect to bacterial diversity in MRONJ patients (Pushalkar et 
al., 2014; Kalyan et al., 2015) but increased Actinomyces spp. accumulation on MRONJ lesions 
is a common finding (Marx et al., 2005; Kos et al., 2010). Moreover, a critical role for bacterial 
infections in MRONJ pathogenesis has been elucidated by studies showing a decrease in ONJ 
incidence in cancer patients who improved their oral hygiene (Ripamonti et al., 2009). 
Existing literature overwhelmingly supports that ART, dental surgery, and local inflammatory 
disease are all risk factors for MRONJ development, however, the role of the microbiota in this 
pathologic condition is controversial. In this study, we investigate the role of the commensal 
microbiota in MRONJ pathogenesis by significantly reducing the oral and gastrointestinal 
microbiota with broad spectrum antibiotics followed by extraction of healthy or periodontally 
diseased teeth in vehicle (Veh) or ZOL treated mice. 
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Materials and Methods 
Animals 
6-week-old female C57BL/6J mice were purchased from the Jackson Laboratories and housed 
in a specific pathogen free (SPF) environment with 12-hour light/dark cycle managed by the 
UCLA Division of Laboratory and Animal Medicine. All experimental protocols were approved by 
institutional guidelines from the Chancellor’s Animal Research Committee (2011-062).  
Commensal microbiota reduction and ligature-induced periodontitis 
SPF mice were randomly assigned into four groups: SPF+no ligature control (NLC), SPF+LIP, 
antibiotic-treated (Abx)+NLC and Abx+LIP groups (n=8 mice each). All Abx animals received 
twice daily intragastric and intraoral gavage of vancomycin (50mg/kg), metronidazole 
(100mg/kg) and neomycin (100mg/kg), with ampicillin (0.5mg/mL) provided in the drinking water 
ad libitum for the first 7 days of the study. Sterile saline gavage and unaltered water were 
delivered to SPF mice. After 7 days, a 6-0 silk suture was aseptically placed on the right and left 
second maxillary molar (M2) of Abx/LIP and SPF/LIP groups. For Abx animals, we maintained 
dysbiosis by delivering vancomycin (0.5mg/mL), ampicillin (1mg/mL) and neomycin (1mg/mL) in 
drinking water ad libitum for the remainder of the study. Three weeks after ligature placement, 
animals were sacrificed.  A schematic illustrating the timeline of the study can be found in 
Figure 3A.  
Commensal microbiota reduction and MRONJ  
SPF mice were randomly assigned into six groups: SPF/Veh/NLC, SPF/ZOL/NLC, 
SPF/ZOL/LIP, Abx/Veh/NLC, Abx/ZOL/NLC, and Abx/ZOL/LIP (n=8-10 mice each). Animals in 
the SPF and Abx groups received unaltered water or antibiotic gavage/water as described 
above for the entire study. Animals receiving Veh and ZOL treatment received biweekly 
intravenous injections of 0.9% NaCl or 125μg/kg Zoledronic acid (Sagent Pharmaceuticals) 
starting one week after the study began and continuing throughout the study. Two weeks after 
the study began, animals in the LIP groups received a ligature as described above. 3 after 
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ligature placement, all animals underwent maxillary M2 extraction. Prior to sacrifice, oral and 
fecal samples were aseptically obtained and weighed. Following sacrifice, spleens and ceca 
were dissected and weights were compared to total body weight.  A schematic illustrating the 
timeline of the study can be found in Figure 4A. 
Micro-computed tomography 
Whole maxillae were scanned with a voxel size of 10μm3 using a 1.0 mm aluminum filter at 60 
kVp and 166μA (SkyScan 1275; Bruker). Other scanning parameters include rotation step of 0.4 
degrees, frame averaging of 6 and random movement. 2-dimensional images were 
reconstructed using N Recon (Bruker) following X-Y alignment and dynamic range adjustment. 
Reconstructed images were saved as 16-bit TIFF images and used for bone loss analysis. Bone 
loss was quantified by measuring the distance between cementoenamel junction and the 
alveolar ridge on the palatal, mesiobuccal and distobuccal roots of M2 using CTAn (Bruker). Net 
bone loss was assessed by subtracting SPF/NLC from SPF/LIP and Abx/NLC from Abx/LIP. 3-
dimensional representative images were generated in CTVox (Bruker).  
Histomorphometric and histochemical staining 
Hematoxylin and eosin and tartrate-resistant acid phosphatase (#387A-1KT, Millipore Sigma) 
staining was performed following decalcification and paraffin embedding as described 
previously (Williams et al., 2014). Quantifications were performed using ImageJ and 
Histomorph(van ’t Hof et al., 2017).  
Quantitative real-time PCR 
Bacterial DNA was extracted from fecal and oral samples of one animal per cage in both SPF 
and Abx groups taken before sacrifice using the DNeasy PowerSoil Kit (Qiagen; #12888-100). 
Real-time PCR of genomic DNA was performed to determine relative 16S rRNA expression in 
SPF and Abx groups using the universal primers (515F 5’-GTGCCAGCMGCCGCGGTAA-3’; 
806R 5’-GGACTACHVGGGTWTCTAAT-3’) with PowerUp SYBR Green Master Mix 
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(#100029284; Applied Biosystems) in a QuantStudio 3 Real-Time PCR System (Applied 
Biosystems). 
16S rRNA sequencing 
Bacterial DNA was extracted from fecal, oral, spleen and liver samples as described above. 
Library preparation was performed as described (Tong et al., 2014) using uniquely barcoded 
primers targeting the V4 region of the 16S gene (Caporaso et al., 2012). Pooled libraries diluted 
to 6pM in 20% PhiX underwent paired-end (2x250bp) sequencing using the Illumina MiSeq v2 
platform. Demultiplexed sequencing results were analyzed with the QIIME pipeline (Caporaso et 
al., 2010).  
Fluorescent in situ hybridization 
Archived MRONJ samples (Williams et al., 2014) were deparaffinized in a 60°C oven and 
rehydrated in serial dilutions of xylene and ethanol. A custom probe targeting position 338-355 
of the 16S rRNA bacterial gene was generated with a Cyanine-3 fluorescent tag for in situ 
hybridization (5’-[Cy3] GCT GCC TCC CGT AGG AGT- 3’; MilliporeSigma). The probe was 
diluted to 1μM in hybridization buffer (0.9M NaCl, 0.1% SDS, 20mM Tris-HCl) and slides were 
incubated for 4 hours at 50°C in a humidified chamber to allow for hybridization. Tissues were 
counterstained with 300nM DAPI for 5 minutes, mounted with Prolong Gold (Thermofisher), 
imaged on a Leica DMI8 epifluorescence microscope and quantified in the provided LAS 
software.  
Statistical analysis 
All data are shown as mean ± SEM. For all figures, differences between groups were compared 
by one- or two-way ANOVA with Tukey’s post-hoc test, as appropriate.  *p < 0.05; **p < 0.01; 
***p < 0.001; ****p < 0.0001; ns, not statistically significant. 
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Results 
MRONJ lesions are associated with increased bacterial infiltrate and antimicrobial gene 
expression 
We previously identified a critical role for IL36 family cytokines in ONJ pathogenesis, whereby 
IL36 signaling disrupts osteomucosal healing by inhibiting collagen synthesis in primary mouse 
gingival mesenchymal stem cells (GMSCs) (Kim et al., 2017). To further understand how IL36 
influences GMSC physiology, we exposed GMSCs to IL36α and performed microarray analysis 
to identify differentially expressed genes (DEG) (Appendix Fig. 1A). Identified DEGs clustered 
within biological pathways related to inflammation and infection, including IL17A signaling in 
fibroblasts, acute phase response signaling and IL6 signaling (Appendix Fig. 1B). Interestingly, 
of the top 10 most upregulated DEGs, 80% (8/10) are known to have direct or indirect 
antimicrobial function (Appendix Fig. 1C) and mapped to a single, highly connected protein 
network of physical and functional associations with IL6, a major effector of immunocompetence 
(Appendix Fig. 1D). The host response to MRONJ-associated cues combined with literature 
that shows IL36 cytokines are released in response to microbial stimulation (Jensen, 2017) 
supports the hypothesis that host defense against microbes may be an important factor in 
MRONJ pathogenesis.  
MRONJ lesions are barrier defects that involve bone exposure in the maxillofacial region which 
inevitably becomes colonized by the oral microbiota. To determine the extent of microbial 
infiltration in murine MRONJ lesions, we assayed tissues generated from a previous study (Fig 
1A, Williams et al., 2014). Utilizing FISH with a universal bacterial probe, we found significantly 
increased bacterial signatures in the connective tissue and epithelium of MRONJ lesions with 
exposed bone and unhealed epithelium compared to vehicle treated controls that had complete 
epithelial closure and no exposed bone (Fig. 1B). This data identifies a bacterial component 
that is unique to MRONJ lesions.  
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Figure 1. Increased microbial infiltrate in MRONJ lesions.  
A. Experimental schematic of the previously published study. B. Fluorescence in situ hybridization of 16S rRNA using 
the universal bacterial probe Eub338 conjugated to Cy3. ES, extraction site; E, epithelium; CT, connective tissue; B, 
bone; Veh, vehicle; ZOL, zoledronic acid. **** p<0.0001. Scale bar: 100μm 
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Broad spectrum antibiotic treatment modifies host physiology and microbiota 
composition 
To understand the role of the microbiota in MRONJ pathogenesis, we utilized a model of 
systemic dysbiosis achieved by drastically reducing the commensal microbiota (Reikvam et al., 
2011). Mice treated with antibiotics (Abx) for at least four weeks showed more than 99% 
decrease in the bacteria-specific 16S rDNA gene expression compared to specific pathogen 
free (SPF) controls from equal amounts of fecal or oral swab material (Fig. 2A). Spleen size as 
a percentage of body weight was almost halved in Abx mice compared to SPF mice (Fig. 2B). 
Conversely, Abx mice developed enlarged ceca that weighed an average of four times more 
than ceca from SPF controls (Fig. 2C). 16S rDNA sequencing of oral swabs revealed 
significantly more alpha diversity in Abx compared to SPF groups (Fig. 2D), while Bray-Curtis 
principal coordinate analysis and taxonomic bar plots showed that SPF and Abx samples were 
comprised of significantly different bacterial taxa (Fig. 2E,F). Together, this data demonstrates a 
robust experimental system to study the role of the oral commensal microbiome in the 
development of oral disease.  
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Figure 2. Broad spectrum antibiotic treatment leads to macroscopic germ-free phenotype in mice.  
Figure 2. Broad spectrum antibiotic treatment leads to macroscopic germ-free phenotype in mice. A. 16S rRNA 
quantitative real-time PCR was performed from genomic DNA extracted from fecal and oral samples collected prior to 
sacrifice. One oral sample fell below the Ct cutoff of 40 and was placed on the X-axis in red. B, C. Spleen (B) and 
cecum (C) weights are presented as a percentage of total animal body weight at the time of sacrifice. Representative 
images of ceca from SPF and Abx groups on the far right. D,E. The alpha (D) and beta (E) diversity of the microbial 
communities found at the site of ligature placement were calculated by Faith’s phylogenetic diversity and Bray-Curtis 
dissimilarity principal component analysis, respectively. F. Microbiome composition is shown at the amplicon 
sequence variant level (ASV). The top 24 ASVs are classified at the highest taxonomic level identified by sequencing. 
s_, species; g_, genus; f_, family. **** p < 0.0001. Scale bar: 10mm.   
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Antibiotic-induced dysbiosis alters maxillary bone homeostasis in health and disease  
To determine how the commensal microbiota influences maxillary bone homeostasis in the 
absence of confounding variables such as ART or tooth extraction, we compared alveolar bone 
height and maxillary bone mass following LIP in SPF and Abx mice (Fig. 3A). μCT imaging and 
cemento-enamel junction (CEJ) to alveolar bone crest (ABC) distance reveal that LIP induces 
significant alveolar bone loss in both SPF and Abx mice compared to no-ligature controls (NLC), 
and there is a significant increase in CEJ-ABC distance in SPF compared to Abx animals with 
LIP (Fig. 3B,C). By the end of the 4 week study there was also a significant increase in CEJ-
ABC distance on buccal roots of SPF/NLC compared to Abx/NLC animals (Fig. 3B,C).  
Gut microbiota perturbation has been shown to regulate long-bone and vertebral bone mass in 
both germ-free and Abx mice (Appendix Fig. 3, Sjögren et al., 2012; Yan et al., 2016). 
However, it is unknown whether disruption of the commensal microbiota alters maxillary bone 
mass in a similar manner. In our model, bone loss on buccal but not palatal roots was 
significantly different between SPF and Abx animals (Fig. 3C). We therefore compared bone 
mass surrounding the buccal roots of each of our four animal cohorts. In contrast to long bone, 
maxillary bone mass and trabecular structure is not significantly altered by systemic dysbiosis. 
Although the relative CEJ-ABC distance was significantly increased, LIP does not alter buccal 
bone mass and trabecular structure in Abx animals whereas buccal bone mass is significantly 
decreased in SPF/LIP animals (Fig. 3D-H). This is evident qualitatively by observing porous 
buccal bone in SPF/LIP animals and smooth buccal bone in Abx/LIP animals (Fig. 3B). This 
suggests that the oral commensal microbiota plays an important role in maxillary bone mass 
regulation in both health and disease.  
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Figure 3. Systemic dysbiosis prevents alveolar bone loss and bone mass reduction following LIP 
A. Schematic of mouse model. Antibiotics were administered by intragastric gavage for the first week and ad libitum 
in drinking water for subsequent weeks. One week after initial antibiotic administration, a 6-0 silk ligature was placed 
around the second maxillary molar. B. Representative buccal views of μCT reconstructed maxillae from SPF (top) or 
Abx (bottom) animals with (right) or without (left) ligature-induced periodontitis. Scale bar (white): 500μm. C. 
Quantification total distance from the cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) measured 
from each of 3 roots on the second maxillary molar. D. Graphical representation of bone included in bone mass 
quantification at the buccal roots of the second maxillary molar. Bone included in analysis has been pseudocolored in 
red for easy visualization. Scale bar (black): 200μm. E-H. 3-dimensional bone morphometric properties of buccal 
bone in (D) including bone mass (E), trabecular thickness (F), trabecular separation (G) and trabecular number (H). 
SPF, specific pathogen free; Abx, antibiotic-treated; NLC, non-ligature control; LIP, ligature-induced periodontitis; MB, 
mesio-buccal; DB, disto-buccal; P, palatal; BV/TV, bone volume per tissue volume; Tb.Th, trabecular thickness; 
Tb.Sp, trabecular separation; Tb.N, trabecular number. ns p>0.05; * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001.  
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Commensal microbiota protects against inflammation induced osteonecrosis 
A histologic hallmark of ZOL-induced osteonecrosis is an increase in empty lacunae which is 
associated with reduced bone remodeling (Bonewald, 2011). To determine the role of the 
commensal microbiota in the pathogenesis of ZOL-induced osteonecrosis, we examined the 
number of empty lacunae and amount of necrotic bone in SPF and Abx animals treated with 
ZOL and LIP (Fig. 4A). ZOL treatment led to a significant increase in empty lacunae and 
necrotic bone compared to Veh treated controls but antibiotic treatment had no influence on 
these metrics (Fig. 4B-D). As expected based on previous findings (Kim et al., 2018), ZOL-
treated mice that had LIP prior to extraction developed significantly more osteonecrosis 
compared to ZOL treatment alone. However, perturbation of the commensal microbiota with 
antibiotics resulted in a further increase in osteonecrosis compared to SPF animals with normal 
microbiota (Fig. 4B-D). This data suggests that disruption of the microbiota with antibiotics 
combined with local inflammation preceding a tooth extraction increases the development of 
osteonecrosis during ZOL therapy.  
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Figure 4: Histologic assessment of osteonecrosis formation in dysbiotic mice.  
A. Hematoxylin and eosin section staining at the site of extraction. Representative images from each animal cohort 
are shown at two magnifications. Scale bar: 100um. B. The number of osteocyte lacunae without nuclear stain were 
quantified as empty lacunae. C. Areas containing more than 3 empty lacunae were quantified as necrotic and are 
presented as a percentage of the total bone present. All quantified data represent mean ± SEM. *p<0.05; ***p<0.001; 
ns, not statistically significant. 
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Antibiotic-induced dysbiosis increases osteoclast number and surface during 
inflammation induced osteonecrosis 
We have previously shown that biweekly ZOL infusions increase TRAP positive osteoclasts 3 
weeks after healthy or diseased tooth extraction occurs (Williams et al., 2014; Kim et al., 2018). 
To understand the role of microbial dysbiosis on resorptive cell numbers and surface area, we 
utilized enzyme histochemistry to identify TRAP positive osteoclasts at the site of extraction in 
Abx and SPF animals (Fig. 5A). ZOL infusions increased osteoclast number (Fig. 5B) and 
surface (Fig. 5C) in both Abx and SPF tissues following healthy tooth extraction. Interestingly, 
Abx tissues from LIP groups showed an increase in both osteoclast number and surface 
compared to SPF tissues (Fig. 5B,C). This data suggests that in the setting of bisphosphonate 
treatment and periodontal inflammation, the commensal microbiota dampens the generation of 
osteoclasts (Fig. 6).   
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Figure 5: Histologic assessment of TRAP-positive osteoclasts in dysbiotic mice.  
A. TRAP staining (purple) with aniline blue counterstain at the site of extraction. Representative images from each 
animal cohort are shown at two magnifications. Scale bar: 100μm. B,C. The number (B) and surface (C) of TRAP
+
 
osteoclasts per bone surface were quantified. Data is presented as mean ± SEM. *p<0.05; ns, not statistically 
significant. 
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Figure 6: Proposed model.  
Antibiotic perturbation of the oral microbiota does not alter the number of osteoclasts or necrotic bone formation 
following extraction of teeth in periodontal health (Left) or extraction of teeth in periodontal health with zoledronic acid 
(ZOL) treatment (Middle). Following extraction of a tooth with periodontal disease combined with ZOL therapy 
antibiotic-induced dysbiosis leads to increases in the amount of necrotic bone and number of osteoclasts at the 
extraction site (Right). Veh, vehicle; NLC, no-ligature control; ZOL, zoledronic acid; LIP, ligature-induced periodontitis. 
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Discussion 
In this study, we provide in vivo evidence of increased bacterial infiltration in murine MRONJ-like 
lesions and show that local cells respond to MRONJ-associated inflammatory cues by 
upregulating antimicrobial genes in vitro (Fig. 1, Appendix Fig. 1). We also demonstrate host 
anatomical and microbiome changes associated with antibiotic-induced microbial reduction (Fig. 
2). We identify the role of the commensal microbiota in LIP-induced bone loss (Fig. 3) and, for 
the first time, show a protective role for the commensal microbiota in inflammation-induced 
osteonecrosis development (Fig. 4,5). Cumulatively, our data reveals insight into how host-
microbe interactions are important for bone physiology in the oral-maxillofacial region.  
The keystone pathogen in periodontitis, Porphyromonas gingivalis, and the pathobionts that 
mediate subsequent inflammatory bone loss are members of the commensal microbiota and 
only become pathogenic under conditions where microbial homeostasis is not maintained 
(Hajishengallis, 2014). To delineate the role of the commensal microbiota in LIP-induced bone 
loss and subsequent osteonecrosis development, we developed a regimen of antibiotic 
treatment modified from Reikvam et al., aimed at significantly depleting the oral and 
gastrointestinal commensal microbiota. To reduce antibiotic resistance, our antibiotic cocktail 
has dual activity against gram positive (vancomycin and ampicillin) and negative (neomycin and 
ampicillin) aerobic bacteria, as well as activity against anaerobic bacteria (metronidazole). A 
potential confounding factor in this schema is non-specific effects from systemic antibiotic 
absorption that cause alterations in bone mass regulation, however BALB/c mice exposed to 
vancomycin (an antibiotic known to be poorly absorbed systemically) displayed the same high 
bone mass phenotype as mice who received a broad spectrum antibiotic cocktail similar to the 
one used in the current study (Yan et al., 2016). 
In our study, Abx mice phenocopied physiologic characteristics of germ-free mice and displayed 
over 99% reduction in oral and gut microbes measured by 16S rDNA expression. The enlarged 
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cecum observed in germ-free and antibiotic-treated mice is a physiologic response to a 
reduction of indigenous gut bacteria. Dysbiosis leads to impaired water absorption in the colon 
but not the cecum causing the ceca of these animals to store an unusually high amount of water 
(Gordon and Pesti, 1971). The spleen is an immune organ that is important in producing and 
storing innate and adaptive immune cells. As the immune system is highly dependent on signals 
from both pathogenic and commensal microbiota, reduced microbiota stimulus in antibiotic 
treated animals leads to reduced spleen size (Kennedy et al., 2018). Taxonomic analysis and 
Bray-Curtis principal coordinate analysis revealed that in addition to a reduction of bacterial 
biomass (Fig. 2A), antibiotic perturbation changed the community composition of bacteria from 
that of mostly Methylobacterium komagatae and Enterobacteriaceae to Bacteroidales family 
S24-7, a family of uncultivatable bacteria primarily found in the gut of laboratory animals 
(Lagkouvardos et al., 2016, Fig 2E,F). These phenotypic characteristics combined with 16S 
rDNA expression and 16S sequencing confirms a significant reduction and alteration of 
indigenous oral microbiota in our study (Fig. 2). 
In our approach, we target the oral and gut microbiota for both practical and clinical reasons. In 
order to completely digest their food and obtain essential nutrients broken down by gut 
microbes, rodents are coprophagic and expose the oral cavity to intestinal microbes during their 
daily routine (Soave and Brand, 1991). This inherent rodent activity would make it impossible to 
reduce the oral microbiota without also reducing the intestinal microbiota in standard solid-
bottom cages. Additionally, our systemic dysbiosis model is clinically relevant because 
conservative treatment strategies include systemic antibiotic treatment in combination with oral 
antibacterial rinses for Stage 0 patients with no clinical signs of MRONJ (Ruggiero et al., 2014).  
MRONJ pathogenesis is still incompletely understood, owing to its relatively recent discovery 
and multifactorial nature. A number of hypotheses to explain its etiology have been proposed 
that include bone remodeling inhibition, infection and inflammation, angiogenesis inhibition, soft 
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tissue toxicity, and innate or acquired immune dysfunction (Aghaloo et al., 2015). Through 
studies in our lab and others, it has become clear that bone remodeling inhibition is a central 
factor in the development of ONJ because current ARTs directly inhibit osteoclastic bone 
resorption (Aghaloo et al., 2011; Williams et al., 2014). Interestingly, the only other class of 
drugs known to cause MRONJ are anti-angiogenic agents such as vascular endothelial growth 
factor inhibitors and tyrosine kinase inhibitors (Nicolatou-Galitis et al., 2012). While these drugs 
are targeted monoclonal antibodies, as a class they have significant untargeted effects on bone 
metabolism (Alemán et al., 2014).  
One effect of ART and anti-angiogenic therapy in rodents is a significant increase in long-bone 
trabecular bone mass (Williams et al., 2014). Significant osteopetrosis is also observed in germ-
free and Abx adult mice (Sjögren et al., 2012; Yan et al., 2016). In Abx mice with biweekly ZOL 
infusions, distal femur trabecular bone mass plateaus at the same level observed in SPF/ZOL 
mice (Appendix Fig. 3). The increased bone mass in Abx/ZOL mice compared to Abx/Veh mice 
is not additive suggesting that Abx-mediated osteopetrosis is driven by a similar mechanism as 
ZOL-mediated osteopetrosis, which is an inhibition of osteoclast function. While in agreement 
with current theories derived from germ-free studies (Ohlsson and Sjögren, 2015), further 
investigation is required to confirm this hypothesis given the inherent immunophenotypic 
differences between germ-free and conventionally raised Abx mice.  
In line with the bone remodeling inhibition hypothesis for MRONJ pathogenesis, we see no 
evidence of osteonecrosis in mice until they are treated with ZOL (Fig. 4). We also observe 
comparable levels of osteonecrosis in ZOL animals regardless of commensal microbiota 
perturbation, as these animals have similar bone mass and amounts of TRAP-positive 
osteoclasts (Fig. 4, 5, Appendix Fig. 3). In the absence of ART, dysbiotic animals with LIP 
maintain a significantly higher local bone mass compared to SPF/LIP animals (Fig. 3D,E). The 
consequence of increased systemic inhibition of osteoclasts by ZOL and local bone mass 
 77 
 
maintenance in Abx/LIP results in significantly more osteonecrosis development in Abx/ZOL/LIP 
compared to SPF/ZOL/LIP animals, which coincides with an increased number of TRAP-
positive osteoclasts (Fig. 4, 5). Therefore, this study provides further evidence that bone 
remodeling inhibition is a critical factor in MRONJ pathogenesis. 
In line with the bone remodeling inhibition hypothesis for MRONJ pathogenesis, we see no 
evidence of osteonecrosis in mice until they are treated with ZOL (Fig. 4). We also observe 
comparable levels of osteonecrosis in ZOL animals regardless of commensal microbiota 
perturbation, as these animals have similar bone mass and amounts of TRAP-positive 
osteoclasts (Fig. 4, 5, Appendix Fig. 3). In the absence of ART, dysbiotic animals with LIP 
maintain a significantly higher local bone mass compared to SPF/LIP animals (Fig. 3D,E). The 
consequence of increased systemic inhibition of osteoclasts by ZOL and local bone mass 
maintenance in Abx/LIP results in significantly more osteonecrosis development in Abx/ZOL/LIP 
compared to SPF/ZOL/LIP animals, which coincides with an increased number of TRAP-
positive osteoclasts (Fig. 4, 5). Therefore, this study provides further evidence that bone 
remodeling inhibition is a critical factor in MRONJ pathogenesis. In the context of our study, the 
increase in TRAP+ osteoclasts combined with an inhibition of bone resorption at the site of 
ligature placement suggests that the oral microbiota has a net catabolic effect on maxillary 
bone. Thus, the increase in necrotic bone seen in Abx/ZOL/LIP mice likely occurs due to a local 
inhibition of bone resorption brought on by the reduction of commensal microbiota. 
Early studies reported that germ-free rats fail to develop significant inflammatory response and 
pathologic bone loss following placement of a ligature for up to 18 weeks (Rovin et al., 1966), 
yet recent work has shown that ligature placement in germ-free mice induces epithelial 
inflammation that is independent of bacterial colonization (Jiao et al., 2013). Additionally, it was 
reported that antibiotic treatment significantly reduces CEJ-ABC distance relative to non-
antibiotic treated mice (Abe and Hajishengallis, 2013) which agrees with our observations (Fig. 
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3B,C). Together, these studies suggest that the ligature itself elicits a host response that likely 
arises from its direct communication with mouse gingival tissue. The constant barrage of 
mechanostimulatory signals from mastication is a unique feature of the oral barrier compared to 
the gut or skin and uniquely drives local immune cell development, including Th17 cells that are 
intimately involved in pathologic periodontal bone loss (Dutzan et al., 2017). Following 
significant reduction of oral microbiota contribution in LIP pathogenesis, we observed increased 
osteonecrosis development in Abx/ZOL/LIP mice, suggesting that trauma or damage is another 
integral factor in MRONJ pathogenesis. In fact, the specificity of MRONJ to the jaw region may 
be due in part to tissue-specific signals that occur in response to mechano-stimulation that 
cause barrier damage. 
In summary, our study reveals that the commensal microbiota protects against osteonecrosis 
development in a mouse model of LIP but has no effect on osteonecrosis development in 
periodontal health. Broad spectrum antibiotic treatment is a recommended strategy in the 
management of MRONJ starting from Stage 0, and while our model represents an amount of 
antibiotic treatment that well exceeds recommendations, it suggests that targeted narrow 
spectrum therapy should be utilized to prevent deleterious disruptions to the commensal 
microbiota.    
  
 79 
 
Appendix 
 
Appendix Figure 1.  
A. Schematic of the in vitro workflow including cell culture, library preparation, and Affymetrix GeneChip Mouse 
Genome 430 2.0 microarray. B. Ingenuity pathway analysis showing the top 5 pathways upregulated in IL-36α treated 
GMSC. Yellow line at 1.3 denotes the boundary of statistical significance correlating to p < 0.05. C. Top 10 
upregulated genes resulting from the microarray analysis color coded based on known direct or indirect antimicrobial 
properties. D. A node-based representation of the predicted and known protein-protein associations between 
upregulated genes in C. The colored lines represent the following: Yellow - predicted interaction from text mining; 
Purple - experimentally determined interaction; Black - co-expressed; Blue - interaction from curated database.  
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Appendix Figure 2.  
A,B. The alpha (A) and beta (B) diversity of the microbial communities found at the site of ligature placement were 
calculated by Faith’s phylogenetic diversity and Bray-Curtis dissimilarity principal component analysis, respectively. 
C. Microbiome composition is shown at the amplicon sequence variant level (ASV). The top 25 ASVs are classified at 
the highest taxonomic level identified. s_, species; g_, genus; f_, family. LIP, ligature-induced periodontitis. 
****p<0.0001. Data is presented as a min/max box and whisker plot.  
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Appendix Figure 3.  
A. Representative images of the metaphyseal trabecular bone from the distal femur. Scale bar: 500μm. B-E. 
Quantification of bone mass (B), trabecular number (C), trabecular thickness (D), and trabecular separation (E) 
measured from the region pictured in (A). SPF, specific pathogen free; Abx, antibiotic treated; Veh, vehicle; ZOL, 
zoledronic acid; BV/TV, bone mass percentage; Tb.N, trabecular number; Tb.Th, trabecular thickness; Tb.Sp, 
trabecular separation. **p<0.01; ***p<0.001.  
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Chapter 4 
 
 
 
 
 
 
 
 
 
 
 
Summary and Conclusions 
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Oral mucosal wound healing is a complex but critical process following dentoalveolar 
surgery that protects the host by re-establishing barrier integrity. MRONJ is a condition that 
results in a non-healing oral wound following dental surgery in some patients taking 
antiresorptive or antiangiogenic medication. Building upon our previous work on MRONJ 
pathophysiology and mechanism, here we investigated two confounding factors that lead to the 
development of MRONJ. The careful manipulation of variables in this work has resulted in a 
better understanding of the complexity involved in this multifactorial disease process.  
In Chapter 2, we assessed the role of chronic periodontal disease in the development of 
osteonecrosis. We found that the increase in alveolar bone loss between acute and chronic 
periodontal disease is not a function of the number or type of local microbes, but rather, is 
associated with high local expression of Il17a, and an increase in osteoclasts and CD3+ T cells. 
When we assessed the role of chronic periodontal disease in MRONJ pathogenesis, we found 
significant development of necrotic bone that was exacerbated by longer periods of pre-existing 
periodontal disease. We also identified two potential systemic markers of periodontal disease 
that may help identify patients at risk of developing MRONJ prior to dental surgery.  
In Chapter 3, we studied the function of the commensal microbiota in osteomucosal 
healing. By depleting the commensal microbiota with high-dose and broad-spectrum antibiotics, 
we identified that the oral microbiota exerts a catabolic effect on alveolar bone in a ligature 
model of periodontal disease. Dysbiosis had no effect on MRONJ development following 
extraction of a healthy tooth, however, local and systemic inhibition of bone resorption by 
antibiotics and BP, respectfully, led to an increase in bone necrosis following extraction of a 
diseased tooth.  
Our findings have broad implications for future studies on MRONJ pathogenesis. It is 
abundantly clear from our studies that resolution of dental disease (e.g. peri-radicular 
inflammation) is critical prior to starting antiresorptive treatment. Moreover, we and others have 
found that necrotic bone begins to form adjacent to diseased teeth prior to extraction, 
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showcasing the importance of dental health maintenance for any patient with a history of 
antiresorptive therapy. In addition, our understanding of how the commensal microbiota 
modifies oral health and homeostasis is in its infancy, and we found that ablation of the 
microbiota can increase the amount of bone necrosis in a periodontal disease MRONJ model. 
Our findings suggest that long-term use of broad-spectrum antibiotics may lead to adverse 
effects in the context of MRONJ development.  
